2015-08-31

c-LEcta Plug & Play Biocats™ – the pathfinder of enzyme catalysis in API synthesis

The great potential of enzymes in the syntheses of chiral molecules, especially small molecule APIs, has not been fully exploited yet. The main reason is that off-the-shelf enzymes on the market simply do not measure up to the expectations of people involved in synthesis development. In order to overcome these hurdles, c-LEcta Plug & Play Biocats™ have been developed based on our experience as a partner for 6 of the top 10 global pharmaceutical companies. They currently comprise Alcohol Dehydrogenases, Transaminases and Nitrilases which were specifically engineered for the needs in organic syntheses and real industrial processes and feature guaranteed commercial availability. The development of c-LEcta Plug & Play Biocats™ has received funding from the European Union's Horizon 2020 research and innovation programme under the Grant Agreement No 674200.

Further information as well as an inquiry form for a specific request can be found on our webpage. Of course you are cordially invited to contact us directly at plugNplay@c-LEcta.com.